Achilles Therapeutics plc ACHL
1.48 0.00 (+0.00%)
At closeMar 20, 2025, 4:00 PM EDT
1.48 Day range 1.48
52-week range unavailable
- YTD
- +29.82%
- 1 year
- +14.73%
Analyst view
Consensus: buy
Buy
Price target (mean) —
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 3
- 2 months ago 3
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 5, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Apr 5, 2024 | Piper Sandler | Downgrade | Overweight | Neutral |
| Dec 14, 2023 | B of A Securities | Downgrade | Buy | Underperform |
| Aug 7, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| May 11, 2023 | Chardan Capital | Maintained | Buy | Buy |
| Dec 7, 2022 | Chardan Capital | Maintained | — | Buy |
| Dec 7, 2022 | Piper Sandler | Maintained | — | Overweight |
| Apr 26, 2021 | JP Morgan | Initiated | — | Underweight |
| Apr 26, 2021 | B of A Securities | Initiated | — | Buy |
| Apr 26, 2021 | Chardan Capital | Initiated | — | Buy |
| Apr 26, 2021 | Piper Sandler | Initiated | — | Overweight |
| Apr 26, 2021 | Oppenheimer | Initiated | — | Outperform |